A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said.

Key Points

  • A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial.
  • The results may point to something “curative,” one expert said.

Stay Informed

This story is actively developing. DigiviNews will continue to provide updates as more information becomes available. Follow us on all social platforms for real-time breaking news coverage in Custom and beyond.